Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCIHirotoshi Watanabe, Takafumi Yokomatsu, Itaru Takamisawa et al.|JAMA|2019Cited by 830
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary SyndromeHirotoshi Watanabe, Motoaki Higuchi, Takeshi Morimoto et al.|JAMA Cardiology|2022Cited by 296
Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary StentsTakeshi Kimura, Ken Kozuma, Takeshi Morimoto et al.|Circulation|2012Cited by 157
An Aspirin-Free Versus Dual Antiplatelet Strategy for Coronary Stenting: STOPDAPT-3 Randomized TrialMasahiro Natsuaki, Takeshi Kimura, Hirotoshi Watanabe et al.|Circulation|2023Cited by 145
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trialMasahiro Natsuaki, Takeshi Kimura, Takeshi Morimoto et al.|Cardiovascular Intervention and Therapeutics|2015Cited by 76